Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Re: Athlete's heart or hypertrophic cardiomyopathy?

× No keyword cloud information.

9 in total

1. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines.

Authors: Barry J Maron; William J McKenna; Gordon K Danielson; Lukas J Kappenberger; Horst J Kuhn; Christine E Seidman; Pravin M Shah; William H Spencer; Paolo Spirito; Folkert J Ten Cate; E Douglas Wigle
Journal: Eur Heart J Date: 2003-11 Impact factor: 29.983

2. Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy.

Authors: Perry M Elliott; Juan R Gimeno; María T Tomé; Jaymin Shah; Deirdre Ward; Rajesh Thaman; Jens Mogensen; William J McKenna
Journal: Eur Heart J Date: 2006-06-05 Impact factor: 29.983

Review 3. Hypertrophic cardiomyopathy: a systematic review.

Authors: Barry J Maron
Journal: JAMA Date: 2002-03-13 Impact factor: 56.272

Review 4. Athlete's heart or hypertrophic cardiomyopathy?

Authors: Jörg Lauschke; Bernhard Maisch
Journal: Clin Res Cardiol Date: 2008-10-13 Impact factor: 5.460

5. Role of transcoronary ablation of septal hypertrophy in patients with hypertrophic cardiomyopathy, New York Heart Association functional class III or IV, and outflow obstruction only under provocable conditions.

Authors: Frank H Gietzen; Christian J Leuner; Ludger Obergassel; Claudia Strunk-Mueller; Horst Kuhn
Journal: Circulation Date: 2002-07-23 Impact factor: 29.690

6. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.

Authors: Horst Kuhn; Thorsten Lawrenz; Frank Lieder; Christian Leuner; Claudia Strunk-Mueller; Ludger Obergassel; Markus Bartelsmeier; Christoph Stellbrink
Journal: Clin Res Cardiol Date: 2007-12-10 Impact factor: 5.460

Review 7. Fabry disease in patients with hypertrophic cardiomyopathy (HCM).

Authors: G Beer; P Reinecke; H E Gabbert; W Hort; H Kuhn
Journal: Z Kardiol Date: 2002-12

Review 8. Hypertrophic cardiomyopathy and other causes of sudden cardiac death in young competitive athletes, with considerations for preparticipation screening and criteria for disqualification.

Authors: Barry J Maron
Journal: Cardiol Clin Date: 2007-08 Impact factor: 2.213

9. Differential diagnosis of hypertrophic cardiomyopathies: typical (subaortic) hypertrophic obstructive cardiomyopathy, atypical (mid-ventricular) hypertrophic obstructive cardiomyopathy and hypertrophic non-obstructive cardiomyopathy.

Authors: H Kuhn; J Mercier; E Köhler; H Frenzel; W Hort; F Loogen
Journal: Eur Heart J Date: 1983-11 Impact factor: 29.983

9 in total